Home About Us FUJIFILM Holdings Corporation’s Digital Transformation(DX) DX Initiatives Initiatives for Products and Services DX AI Development platform “SYNAPSE Creative Space”

Initiatives for Products and Services DX

AI Development platform “SYNAPSE  Creative Space”

SYNAPSE Creative Space, a cloud-based AI development support platform, enables users to execute a series of processes for developing image diagnosis AI without requiring any programming expertise. Currently available in its beta version, the service is scheduled to be officially launched in FY2023. There are three major hurdles for doctors in the medical field when developing image diagnosis AI.

  • Requires a high level of engineering knowledge
  • High workload for setting up the development environment, such as securing high-performance servers
  • High workload for physicians in annotation*1 and project management

SYNAPSE Creative Space is an all-in-one AI development platform equipped with all the necessary tools to develop AI, including project management, annotation, machine learning, and AI execution. This service eliminates the aforementioned hurdles, supports physician-led AI development, and promotes the democratization of medical AI development.

 

  • *1 Annotation :process of adding accurate information, such as marking specific areas on image data.
Functions of SYNAPSE Creative Space
Workflow of using SYNAPSE Creative Space

Additionally, we aim to accelerate the social implementation of AI by delivering the AI researched and developed on the SYNAPSE Creative Space to clinical sites through the Fujifilm Group’s platform. For medical institutions and research organizations, this will clarify the path from research to social implementation and enable revenue generation. We aim to build an ecosystem, from development to social implementation, that creates a win-win situation for both industry and academia.